Baird analyst Eric Coldwell raised the firm’s price target on Charles River (CRL) to $118 from $101 and keeps a Neutral rating on the shares. The firm updated its model and designated Charles River as a Bullish Fresh Pick
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRL:
- Charles River price target lowered to $150 from $185 at BofA
- Charles River Labs: Hold Rating Amid Uncertain R&D Growth and FDA Policy Impact
- FDA ‘surprise’ proposal adds uncertainty for Charles River, says Morgan Stanley
- FDA move away from animals negative for Charles River, says JPMorgan
- Hold Rating for Charles River Labs Amid Uncertainty Over FDA’s Shift to Non-Animal Testing